{"mainPropery":{"diseaseId":10477,"diseaseName":"Spinocerebellar ataxia 15","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10477/spinocerebellar-ataxia-15","synonyms":["SCA15","Spinocerebellar ataxia type 15","SCA16 (formerly)","Spinocerebellar ataxia 16 (formerly)"],"synonyms-with-source":[{"name":"SCA15"},{"name":"Spinocerebellar ataxia type 15"},{"name":"SCA16 (formerly)"},{"name":"Spinocerebellar ataxia 16 (formerly)"}],"identifiers":[{"identifierType":"OMIM","identifierId":"606658"},{"identifierType":"ORPHANET","identifierId":"98769"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":44,"resourceName":"National Ataxia Foundation","abbreviation":"","address1":"600 Highway 169 South","address2":"Suite 1725","address3":"","address4":"","address5":"","city":"Minneapolis","state":"MN","zip":"55426","country":"United States","phone":"+1-763-553-0020","tty":"","tollFree":"","fax":"+1-763-553-0167","email":"naf@ataxia.org","url":"https://ataxia.org/","freeText":""},{"resourceID":46,"resourceName":"euro-ATAXIA (European Federation of Hereditary Ataxias)","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"https://www.euroataxia.org/","freeText":""},{"resourceID":403,"resourceName":"Ataxia UK","abbreviation":"","address1":"12 Broadbent Close ","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":" N6 5JW","country":"United Kingdom","phone":"020 7582 1444 ","tty":"","tollFree":"0845 644 0606 (Helpline)","fax":"","email":"helpline@ataxia.org.uk","url":"https://www.ataxia.org.uk/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/606658' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=606658' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Spinocerebellar ataxia 15. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1110,"resourceId":1792,"resourceName":"Univ Washington - testing for spinocerebellar ataxias","descriptionText":"<a href='http://depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf' target='_blank'>Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing</a> is a booklet providing information about spinocerebellar ataxia and is available as a PDF document on the University of Washington Medical Center Web site. Click on the title above to view this resource.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1847725' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022500' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1533,"resourceId":2164,"resourceName":"National Center for Biotechnology Information","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gnd&part=spinocerebellarataxia' target='_blank'>National Center for Biotechnology Information</a> (NCBI) was established in 1988 as a national resource for molecular biology information.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98769' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=sca15' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1892,"resourceId":44,"resourceName":"National Ataxia Foundation","descriptionText":"The <a href='https://ataxia.org/neurologists-and-specialty-clinics/#AtaxiaClinics' target='_blank'>National Ataxia Foundation</a>, a nonprofit organization dedicated to improving the lives of persons affected by ataxia, provides lists of neurologists, ataxia clinics, and movement disorder clinics.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2076,"resourceId":2843,"resourceName":"Coordination of Rare Diseases at Sanford (CoRDS)","descriptionText":"<a href='http://www.sanfordresearch.org/cords/patientsfamilies/' target='_blank'>Coordination of Rare Diseases at Sanford (CoRDS)</a> hosts a specific registry for patients with ataxia in partnership with the National Ataxia Foundation. The goal of the CoRDS registry is to connect as many patients and researchers as possible to help advance treatments and cures for rare diseases. The CoRDS registry is free for patients to enroll and for researchers to access.","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:606658' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6689,"questionText":"What is spinocerebellar ataxia 15?","answerText":"<strong>Spinocerebellar ataxia 15</strong> (SCA15) is a neurological condition characterized by slowly progressive gait and limb <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003198.htm\" target=_blank>ataxia</a>, often in combination with eye movement abnormalities and &nbsp;balance, speech and swallowing difficulties. The onset of symptoms typically&nbsp;occurs&nbsp;between ages&nbsp;7 and 66 years.&nbsp;The ability to walk independently is often maintained for many years following onset of symptoms. SCA15 is caused by mutations in the&nbsp;<a href=\"http://www.ghr.nlm.nih.gov/gene/ITPR1\" target=_blank><em>ITPR1</em></a>&nbsp;gene. It is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> manner. Diagnosis is based on clinical history, physical examination, molecular genetic testing, and exclusion of other similar diseases. There is no effective treatment known&nbsp;to modify disease progression. Patients may benefit from occupational and physical therapy for gait dysfunction and speech therapy for <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007470.htm\" target=_blank>dysarthria</a>.[5782]&nbsp;","dateModified":"2013-01-22T18:54:00"},"basicQuestions":[{"questionId":6690,"questionText":"What are the symptoms of spinocerebellar ataxia 15?","answerText":"Spinocerebellar ataxia 15 (SCA15) is characterized by slowly progressive gait and limb <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003198.htm\" target=_blank>ataxia</a>, often in combination with ataxic <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007470.htm\" target=_blank>dysarthria</a>, <a href=\"http://dictionary.reference.com/browse/titubation\" target=_blank>titubation</a>, upper limb postural tremor (which occurs when&nbsp;a person tries to maintain a position against gravity, such as holding the arms outstretched), mild hyperreflexia (exaggerated reflexes), gaze-evoked <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003037.htm\" target=_blank>nystagmus</a>, and impaired vestibulo-ocular reflex gain (an inability to stabilize the eyes during small head tremors, which makes it difficult to read, etc.).&nbsp;Mild <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007543.htm\" target=_blank>dysphagia</a> and movement-induced oscillopsia (a bouncing and blurring of vision) have been observed in&nbsp;some patients. Symptoms typically present between the ages of&nbsp;7 and 66 years. Gait ataxia and&nbsp;tremor are often the first noticeable symptoms.&nbsp;The ability to walk&nbsp;independently may be maintained for many years (or even decades)&nbsp;following onset of symptoms.[5782]","dateModified":"2013-01-22T19:04:00","resourceClassificationName":"Symptoms","references":[{"referenceId":5782,"authors":"Storey E","articleTitle":"Spinocerebellar Ataxia Type 15","bookWebsiteJournalTitle":"GeneReviews","date":"April 2011","url":"http://www.ncbi.nlm.nih.gov/books/NBK1362/","dateAccessed":"2013-01-22T00:00:00"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12858,"relatedDiseaseName":"Autosomal Dominant Cerebellar Ataxias","relation":"Parent","isRare":false,"hasGardPage":false},{"relatedDiseaseId":6614,"relatedDiseaseName":"Hereditary ataxia","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10748,"relatedDiseaseName":"Spinocerebellar ataxia","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8731,"phenoTypeName":"Cerebellar atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13455,"phenoTypeName":"Gait ataxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11427,"phenoTypeName":"Head tremor","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13678,"phenoTypeName":"Upper limb postural tremor","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6254,"phenoTypeName":"Adult onset","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","percentRanges":"-"},{"phenoTypeId":10111,"phenoTypeName":"Dysmetric saccades","percentRanges":"-"},{"phenoTypeId":14415,"phenoTypeName":"Gaze-evoked horizontal nystagmus","percentRanges":"-"},{"phenoTypeId":8456,"phenoTypeName":"Impaired smooth pursuit","percentRanges":"-"},{"phenoTypeId":12793,"phenoTypeName":"Juvenile onset","percentRanges":"-"},{"phenoTypeId":13459,"phenoTypeName":"Limb ataxia","percentRanges":"-"},{"phenoTypeId":13849,"phenoTypeName":"Postural tremor","percentRanges":"-"},{"phenoTypeId":13843,"phenoTypeName":"Scanning speech","percentRanges":"-"},{"phenoTypeId":5256,"phenoTypeName":"Slow progression","percentRanges":"-"},{"phenoTypeId":13711,"phenoTypeName":"Truncal ataxia","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Spinocerebellar_ataxia_15"}